查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587598

2030 年製藥自動化市場預測：按產品、工作流程類型、自動化規模、技術、應用、最終用戶和地區進行的全球分析

Pharmaceutical Automation Market Forecasts to 2030 - Global Analysis By Product, Workflow Type, Scale of Automation, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2024年全球製藥自動化市場規模將達57.9億美元，預計2030年將達到94.6億美元，預測期內複合年成長率為9.8%。

製藥自動化是指使用科技和機械來簡化和增強製藥業的流程。這包括自動化任務，如配方、包裝、標籤和品管，以提高效率、減少人為錯誤並確保符合監管標準。透過整合這些技術，製藥公司可以提高生產力，降低業務成本，並最終為患者提供更安全、更有效的藥物。

根據全國社區藥劑師協會 2020 年 4 月進行的一項調查，大約 90% 的社區藥局根據 CARES 法案申請了聯邦小型企業援助。

慢性病增加

糖尿病、心血管疾病和癌症等慢性疾病的增加正在推動對高效、可擴展的製藥生產的需求。隨著製藥公司努力滿足不斷成長的藥品需求，自動化技術可以增強製造流程，從而加快生產速度並改善品管。自動化系統可以簡化工作流程，最大限度地減少人為錯誤，並確保一致的產品質量，這對於慢性病管理至關重要。

複雜的整合

製藥自動化的整合複雜性源自於需要將先進技術與現有系統和流程同步，這通常涉及遺留設備和不同的軟體平台。這種整合在技術上具有挑戰性，需要大量時間和資源來確保相容性和效率。這種複雜性可能會導致計劃進度更長、成本更高以及生產中斷。結果，市場擴張受到阻礙。

擴大轉向客製化治療

自動化技術使製藥公司能夠快速調整其生產線來生產個人化藥物，同時確保精確的劑量和劑量以滿足患者的需求。這種製造彈性縮短了新治療方法的上市時間，並增強了滿足特定監管要求的能力。此外，自動化系統改善了資料管理和可追溯性，這對於追蹤個人化治療結果至關重要，從而推動了製藥業對先進自動化解決方案的需求。

初始投資高

製藥自動化的初始投資較高是由於先進技術、設備和系統整合的相關成本。實施自動化解決方案需要大量的機械、軟體和人力資源資本，這可能令人望而卻步，特別是對於中小型企業而言。這種經濟負擔可能會阻礙對自動化的投資並限制市場內的成長機會。

COVID-19 的影響

隨著公司尋求簡化藥品生產並確保安全，COVID-19 大流行顯著加速了製藥自動化市場的發展。對疫苗和治療方法的迫切需求導致對機器人和人工智慧等自動化技術的投資增加，以簡化製造流程。此外，疫情凸顯了數位轉型和即時資料管理對於維持供應鏈彈性的重要性。因此，在對創新解決方案的持續需求和業務效率提高的推動下，製藥自動化市場預計將成長。

雲端運算產業預計將在預測期內成為最大的產業

預計雲端運算領域將在整個預測期內獲得最大的市場佔有率。雲端運算技術為資料儲存、管理和分析提供可擴展且靈活的解決方案，正在徹底改變製藥自動化。實現對關鍵資訊的即時訪問，並促進研究、製造和監管團隊之間的無縫協作。透過利用雲端技術，製藥公司可以提高業務效率、降低成本、縮短藥物開發時間，並最終改善患者治療效果。

預計生產和製造領域在預測期內複合年成長率最高。

由於藥物開發的效率、準確性和合規性提高，預計生產和製造業在預測期內將出現最高的複合年成長率。自動化系統簡化了配方、包裝、標籤和品管等流程，減少了人為錯誤並提高了吞吐量。自動化還實現了靈活的製造，使公司能夠快速回應不斷變化的市場需求和個人化醫療。總的來說，這些應用程式有助於提高業務效率並縮短時間。

比最大的地區

由於慢性病的增加，預計亞太地區在預測期內將創下最大的市場佔有率。中國和印度等國家正大力投資自動化技術。該地區製藥業的成長，加上機器人、人工智慧和機器學習的進步，正在推動這一轉變。此外，對生物製藥行業研發和擴張的持續關注進一步推動了整個全部區域自動化解決方案的採用。

複合年成長率最高的地區：

預計北美在預測期內的複合年成長率最高。美國和加拿大處於領先地位，投資機器人、人工智慧和先進製造系統，以提高業務效率並確保監管合規。該地區專注於研發，對個人化醫療和生技藥品的需求不斷成長，刺激了自動化技術的採用。此外，COVID-19 大流行加速了自動化的發展，凸顯了對彈性和敏捷製造流程的需求。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球製藥自動化市場：依產品

  • 自動化設備
    • 機器人技術
    • 自動導引運輸車（AGV）
    • 自動化立體倉庫系統（AS/RS）
  • 軟體解決方案
    • 製造執行系統（MES）
    • 實驗室資訊管理系統（LIMS）
    • 供應鏈管理軟體
  • 服務
    • 諮詢
    • 綜合服務
    • 維護與支援

第6章全球製藥自動化市場：依工作流程類型

  • 分析前
  • 分析性的
  • 分析後

第7章全球製藥自動化市場：依自動化規模分類

  • 手動整合
  • 部分自動化
  • 全自動

第8章全球製藥自動化市場：依技術分類

  • 人工智慧（AI）
  • 物聯網 (IoT)
  • 機器學習
  • 雲端運算
  • 資料分析
  • 其他技術

第9章全球製藥自動化市場：依應用分類

  • 藥物發現
  • 臨床試驗
  • 生產製造
  • 品管與保證
  • 監理合規性
  • 其他用途

第10章全球製藥自動化市場：依最終用戶分類

  • 藥品製造商
  • 受託研究機構（CRO）
  • 契約製造組織 (CMO)
  • 生技公司
  • 研究所
  • 其他最終用戶

第11章全球製藥自動化市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章 公司概況

  • Siemens AG
  • Rockwell Automation Inc.
  • ABB Limited
  • Honeywell International Inc.
  • Emerson Electric Corporation
  • Schneider Electric SE
  • Mitsubishi Electric Corporation
  • Bosch Rexroth AG
  • Yokogawa Electric Corporation
  • Omron Corporation
  • KUKA AG
  • Fanuc Corporation
  • Adept Technology Inc.
  • Parker Hannifin Corporation
  • Datalogic SpA
  • Panasonic Corporation
  • GE Healthcare
  • Ametek Inc.
  • Festo AG & Co. KG
  • B&R Industrial Automation
  • ArisGlobal
  • Beckhoff Automation GmbH
Product Code: SMRC27583

According to Stratistics MRC, the Global Pharmaceutical Automation Market is accounted for $5.79 billion in 2024 and is expected to reach $9.46 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Pharmaceutical automation refers to the use of technology and machinery to streamline and enhance processes within the pharmaceutical industry. This includes automating tasks such as drug formulation, packaging, labeling, and quality control to improve efficiency, reduce human error, and ensure compliance with regulatory standards. By integrating these technologies, pharmaceutical companies can enhance productivity, reduce operational costs, and ultimately deliver safer and more effective medications to patients.

According to a study conducted by the National Community Pharmacists Association in April 2020, around 90% of community pharmacies were applying for small business federal aid under the CARES Act.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer increases the demand for efficient and scalable drug production. As pharmaceutical companies strive to meet the growing need for medications, automation technologies enhance manufacturing processes, allowing for quicker production and improved quality control. Automated systems can streamline workflows, minimize human error, and ensure consistent product quality, which is crucial for chronic disease management.

Restraint:

Complexity of integration

The complexity of integration in pharmaceutical automation arises from the need to synchronize advanced technologies with existing systems and processes, which often involves legacy equipment and diverse software platforms. This integration can be technically challenging, requiring significant time and resources to ensure compatibility and efficiency. Such complexities can lead to prolonged project timelines, increased costs, and potential disruptions in production. As a result, it impedes the market expansion.

Opportunity:

Growing shift towards customized treatments

Automation technologies enable pharmaceutical companies to quickly adapt production lines to create individualized medications, ensuring precise dosages and formulations tailored to patient needs. This agility in manufacturing reduces time-to-market for new therapies and enhances the ability to meet specific regulatory requirements. Additionally, automated systems improve data management and traceability, essential for tracking personalized treatment outcomes, thereby driving the demand for advanced automation solutions within the pharmaceutical industry.

Threat:

High initial investment

The high initial investment in pharmaceutical automation stems from the costs associated with advanced technologies, equipment, and system integration. Implementing automation solutions requires significant capital for machinery, software, and training personnel, which can be prohibitive, especially for small to mid-sized companies. This financial burden may deter investment in automation, limiting growth opportunities within the market.

Covid-19 Impact

The covid-19 pandemic significantly accelerated the pharmaceutical automation market, as companies sought to enhance efficiency and ensure safety in drug production. The urgent need for vaccines and treatments led to increased investments in automation technologies, such as robotics and AI, to streamline manufacturing processes. Additionally, the pandemic highlighted the importance of digital transformation and real-time data management in maintaining supply chain resilience. As a result, the pharmaceutical automation market is expected to grow, driven by ongoing demand for innovative solutions and improved operational efficiencies.

The cloud computing segment is expected to be the largest during the forecast period

The cloud computing segment is predicted to secure the largest market share throughout the forecast period. Cloud computing technology is revolutionizing pharmaceutical automation by providing scalable and flexible solutions for data storage, management, and analysis. It enables real-time access to critical information, facilitating seamless collaboration among research, manufacturing, and regulatory teams. By leveraging cloud technology, pharmaceutical companies can improve operational efficiency, reduce costs, and accelerate drug development timelines, ultimately leading to better patient outcomes.

The production & manufacturing segment is expected to have the highest CAGR during the forecast period

The production & manufacturing segment is anticipated to witness the highest CAGR during the forecast period fuelled by its enhanced efficiency, accuracy, and compliance in drug development. Automated systems streamline processes such as formulation, packaging, labeling, and quality control, reducing human error and increasing throughput. Automation also facilitates flexible manufacturing, allowing companies to quickly adapt to changing market demands and personalized medicine. Overall, these applications contribute to improved operational efficiency and faster time-to-market for pharmaceuticals.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period driven by rising prevalence of chronic diseases. Countries like China and India are investing heavily in automation technologies. The region's growing pharmaceutical industry, coupled with advancements in robotics, artificial intelligence, and machine learning, is facilitating this transformation. Additionally, the ongoing focus on research and development, along with an expanding biopharmaceutical sector, is further propelling the adoption of automation solutions across the region.

Region with highest CAGR:

North America is projected to witness the highest CAGR over the forecast period. The United States and Canada are leading this trend, with investments in robotics, artificial intelligence, and advanced manufacturing systems to enhance operational efficiency and ensure regulatory compliance. The region's strong emphasis on research and development, alongside the rising demand for personalized medicine and biologics, is fueling the adoption of automation technologies. Furthermore, the covid-19 pandemic has accelerated the push towards automation, emphasizing the need for resilient and agile manufacturing processes.

Key players in the market

Some of the key players profiled in the Pharmaceutical Automation Market include Siemens AG, Rockwell Automation Inc., ABB Limited, Honeywell International Inc., Emerson Electric Corporation, Schneider Electric SE, Mitsubishi Electric Corporation, Bosch Rexroth AG, Yokogawa Electric Corporation, Omron Corporation, KUKA AG, Fanuc Corporation, Adept Technology Inc., Parker Hannifin Corporation, Datalogic S.p.A., Panasonic Corporation, GE Healthcare, Ametek Inc., Festo AG & Co. KG, B&R Industrial Automation, ArisGlobal and Beckhoff Automation GmbH.

Key Developments:

In May 2024, ArisGlobal unveiled its enhanced LifeSphere Automation Engine, a significant advancement aimed at revolutionizing the pharmaceutical industry's safety and regulatory processes. This launch emphasizes the integration of artificial intelligence (AI) into the company's existing framework, enabling pharmaceutical organizations to streamline their operations and enhance data management capabilities.

In April 2024, GE Healthcare unveiled its suite of AI-Enhanced Personalized Oncology Solutions. This innovative technology is designed to significantly improve the precision and effectiveness of cancer treatments through advanced automation and machine learning techniques. This personalization is expected to enhance outcomes by aligning therapies more closely with patients' specific cancer profiles.

Products Covered:

  • Automated Equipment
  • Software Solutions
  • Services

Workflow Types Covered:

  • Pre-analytical
  • Analytical
  • Post-analytical

Scale of Automations Covered:

  • Manual Integration
  • Partial Automation
  • Full Automation

Technologies Covered:

  • Artificial Intelligence (AI)
  • Internet of Things (IoT)
  • Machine Learning
  • Cloud Computing
  • Data Analytics
  • Other Technologies

Applications Covered:

  • Drug Discovery
  • Clinical Trials
  • Production & Manufacturing
  • Quality Control & Assurance
  • Regulatory Compliance
  • Other Applications

End Users Covered:

  • Pharmaceutical Manufacturers
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Biotechnology Companies
  • Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Automation Market, By Product

  • 5.1 Introduction
  • 5.2 Automated Equipment
    • 5.2.1 Robotics
    • 5.2.2 Automated Guided Vehicles (AGVs)
    • 5.2.3 Automated Storage & Retrieval Systems (AS/RS)
  • 5.3 Software Solutions
    • 5.3.1 Manufacturing Execution Systems (MES)
    • 5.3.2 Laboratory Information Management Systems (LIMS)
    • 5.3.3 Supply Chain Management Software
  • 5.4 Services
    • 5.4.1 Consulting
    • 5.4.2 Integration Services
    • 5.4.3 Maintenance & Support

6 Global Pharmaceutical Automation Market, By Workflow Type

  • 6.1 Introduction
  • 6.2 Pre-analytical
  • 6.3 Analytical
  • 6.4 Post-analytical

7 Global Pharmaceutical Automation Market, By Scale of Automation

  • 7.1 Introduction
  • 7.2 Manual Integration
  • 7.3 Partial Automation
  • 7.4 Full Automation

8 Global Pharmaceutical Automation Market, By Technology

  • 8.1 Introduction
  • 8.2 Artificial Intelligence (AI)
  • 8.3 Internet of Things (IoT)
  • 8.4 Machine Learning
  • 8.5 Cloud Computing
  • 8.6 Data Analytics
  • 8.7 Other Technologies

9 Global Pharmaceutical Automation Market, By Application

  • 9.1 Introduction
  • 9.2 Drug Discovery
  • 9.3 Clinical Trials
  • 9.4 Production & Manufacturing
  • 9.5 Quality Control & Assurance
  • 9.6 Regulatory Compliance
  • 9.7 Other Applications

10 Global Pharmaceutical Automation Market, By End User

  • 10.1 Introduction
  • 10.2 Pharmaceutical Manufacturers
  • 10.3 Contract Research Organizations (CROs)
  • 10.4 Contract Manufacturing Organizations (CMOs)
  • 10.5 Biotechnology Companies
  • 10.6 Research Institutions
  • 10.7 Other End Users

11 Global Pharmaceutical Automation Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Siemens AG
  • 13.2 Rockwell Automation Inc.
  • 13.3 ABB Limited
  • 13.4 Honeywell International Inc.
  • 13.5 Emerson Electric Corporation
  • 13.6 Schneider Electric SE
  • 13.7 Mitsubishi Electric Corporation
  • 13.8 Bosch Rexroth AG
  • 13.9 Yokogawa Electric Corporation
  • 13.10 Omron Corporation
  • 13.11 KUKA AG
  • 13.12 Fanuc Corporation
  • 13.13 Adept Technology Inc.
  • 13.14 Parker Hannifin Corporation
  • 13.15 Datalogic S.p.A.
  • 13.16 Panasonic Corporation
  • 13.17 GE Healthcare
  • 13.18 Ametek Inc.
  • 13.19 Festo AG & Co. KG
  • 13.20 B&R Industrial Automation
  • 13.21 ArisGlobal
  • 13.22 Beckhoff Automation GmbH

List of Tables

  • Table 1 Global Pharmaceutical Automation Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Pharmaceutical Automation Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Pharmaceutical Automation Market Outlook, By Automated Equipment (2022-2030) ($MN)
  • Table 4 Global Pharmaceutical Automation Market Outlook, By Robotics (2022-2030) ($MN)
  • Table 5 Global Pharmaceutical Automation Market Outlook, By Automated Guided Vehicles (AGVs) (2022-2030) ($MN)
  • Table 6 Global Pharmaceutical Automation Market Outlook, By Automated Storage & Retrieval Systems (AS/RS) (2022-2030) ($MN)
  • Table 7 Global Pharmaceutical Automation Market Outlook, By Software Solutions (2022-2030) ($MN)
  • Table 8 Global Pharmaceutical Automation Market Outlook, By Manufacturing Execution Systems (MES) (2022-2030) ($MN)
  • Table 9 Global Pharmaceutical Automation Market Outlook, By Laboratory Information Management Systems (LIMS) (2022-2030) ($MN)
  • Table 10 Global Pharmaceutical Automation Market Outlook, By Supply Chain Management Software (2022-2030) ($MN)
  • Table 11 Global Pharmaceutical Automation Market Outlook, By Services (2022-2030) ($MN)
  • Table 12 Global Pharmaceutical Automation Market Outlook, By Consulting (2022-2030) ($MN)
  • Table 13 Global Pharmaceutical Automation Market Outlook, By Integration Services (2022-2030) ($MN)
  • Table 14 Global Pharmaceutical Automation Market Outlook, By Maintenance & Support (2022-2030) ($MN)
  • Table 15 Global Pharmaceutical Automation Market Outlook, By Workflow Type (2022-2030) ($MN)
  • Table 16 Global Pharmaceutical Automation Market Outlook, By Pre-analytical (2022-2030) ($MN)
  • Table 17 Global Pharmaceutical Automation Market Outlook, By Analytical (2022-2030) ($MN)
  • Table 18 Global Pharmaceutical Automation Market Outlook, By Post-analytical (2022-2030) ($MN)
  • Table 19 Global Pharmaceutical Automation Market Outlook, By Scale of Automation (2022-2030) ($MN)
  • Table 20 Global Pharmaceutical Automation Market Outlook, By Manual Integration (2022-2030) ($MN)
  • Table 21 Global Pharmaceutical Automation Market Outlook, By Partial Automation (2022-2030) ($MN)
  • Table 22 Global Pharmaceutical Automation Market Outlook, By Full Automation (2022-2030) ($MN)
  • Table 23 Global Pharmaceutical Automation Market Outlook, By Technology (2022-2030) ($MN)
  • Table 24 Global Pharmaceutical Automation Market Outlook, By Artificial Intelligence (AI) (2022-2030) ($MN)
  • Table 25 Global Pharmaceutical Automation Market Outlook, By Internet of Things (IoT) (2022-2030) ($MN)
  • Table 26 Global Pharmaceutical Automation Market Outlook, By Machine Learning (2022-2030) ($MN)
  • Table 27 Global Pharmaceutical Automation Market Outlook, By Cloud Computing (2022-2030) ($MN)
  • Table 28 Global Pharmaceutical Automation Market Outlook, By Data Analytics (2022-2030) ($MN)
  • Table 29 Global Pharmaceutical Automation Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 30 Global Pharmaceutical Automation Market Outlook, By Application (2022-2030) ($MN)
  • Table 31 Global Pharmaceutical Automation Market Outlook, By Drug Discovery (2022-2030) ($MN)
  • Table 32 Global Pharmaceutical Automation Market Outlook, By Clinical Trials (2022-2030) ($MN)
  • Table 33 Global Pharmaceutical Automation Market Outlook, By Production & Manufacturing (2022-2030) ($MN)
  • Table 34 Global Pharmaceutical Automation Market Outlook, By Quality Control & Assurance (2022-2030) ($MN)
  • Table 35 Global Pharmaceutical Automation Market Outlook, By Regulatory Compliance (2022-2030) ($MN)
  • Table 36 Global Pharmaceutical Automation Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 37 Global Pharmaceutical Automation Market Outlook, By End User (2022-2030) ($MN)
  • Table 38 Global Pharmaceutical Automation Market Outlook, By Pharmaceutical Manufacturers (2022-2030) ($MN)
  • Table 39 Global Pharmaceutical Automation Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
  • Table 40 Global Pharmaceutical Automation Market Outlook, By Contract Manufacturing Organizations (CMOs) (2022-2030) ($MN)
  • Table 41 Global Pharmaceutical Automation Market Outlook, By Biotechnology Companies (2022-2030) ($MN)
  • Table 42 Global Pharmaceutical Automation Market Outlook, By Research Institutions (2022-2030) ($MN)
  • Table 43 Global Pharmaceutical Automation Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.